Smith & Nephew plc is a global medical technology company that designs, manufactures and markets advanced medical devices for use in orthopaedic reconstruction, endoscopic procedures and wound management. The company’s innovations span joint replacement systems, minimally invasive surgical tools and advanced wound care products, serving surgeons, hospitals and outpatient facilities worldwide.
Across its Orthopaedics segment, Smith & Nephew offers hip and knee arthroplasty systems, trauma fixation devices and sports medicine solutions for ligament repair and soft tissue reconstruction. Its Endoscopy division provides fluid management platforms, arthroscopic and laparoscopic instruments, as well as diagnostic and therapeutic endoscopy products. In Advanced Wound Management, the company markets negative pressure wound therapy systems, compression garments and a portfolio of alginate, foam and antimicrobial dressings.
Founded in Hull, England in 1856 by Thomas James Smith, the firm adopted the Smith & Nephew name when his nephew Horatio Nelson Smith joined in 1896. Over more than a century of development, the company has expanded its R&D footprint across Europe, North America and Asia, establishing manufacturing sites and innovation centers focused on digital surgery and tissue regeneration. Today, Chief Executive Officer Roland Diggelmann leads a senior management team committed to advancing patient outcomes through minimally invasive and tissue-preserving interventions.
Smith & Nephew’s products are distributed in more than 100 countries, with regional headquarters in the Americas, Europe, Asia Pacific and the Middle East & Africa. The company collaborates with healthcare providers, research institutions and professional societies to support clinical education and drive adoption of its technologies in hospital networks, ambulatory surgical centers and specialized wound clinics around the globe.
AI Generated. May Contain Errors.
